Race for coronavirus treatment - As the global race continues to try and find a treatment for coronavirus the UK biotech firm Synairgen is reportedly planning to trial its experimental lung drug on Covid-19 patients.
The company received the green light from UK regulators to conduct a trial of its lead drug SNG001 at NHS trusts across the country.
The inhaled drug has been in development as a treatment for chronic-obstructive pulmonary disorder (COPD), a severe lung disease, but this has been paused to conduct testing on 100 patients who have been diagnosed with Covid-19.
It was identified in a WHO analysis of potential treatments against the coronavirus. Patients can self-administer it, through a small hand-held battery-operated nebulizer.
The trial is due to start next week.
A French government spokesperson has said that the 6pm curfew is "relatively effective" but "not sufficient at this stage". ...
Read More
Monaco has decided to extend all current health measures until February 19th.
Read More
The European Commission has recommended that all governments prevent “non-essential” travel to the Provence Alpes Côte d’Azur region in an attempt to ...
Read More
Several mayors in the Alpes-Maritimes have issued a joint open letter saying that they note the fall in the number of doses for vaccination centers an...
Read More
Local MP Eric Ciotti has criticised what he calls the French government’s “procrastination” in the face of Covid health crisis. While speaking to Fren...
Read More
